Skip navigation

Improve Chargeback Efficiency, Navigate Classes of Trade, Streamline GPO Membership Management and Optimize Contract Administration for Improved Net Results

June 25-26, 2019
  • Philadelphia, PA

BREAKING NEWS IMPACTING MANUFACTURERS: The administration’s point-of-sale-rebate proposal is expected to be a final rule in the coming months. It focuses on Medicare and has a 2020 implementation date, excluding from safe harbor protection (under the Anti-Kickback Statute) rebates on drugs. Companies must rethink how they price, contract, distribute and position products within this changing marketplace. Key players within the drug distribution channel will offer ways to operationalize these sweeping changes, with chargebacks being a key mechanism at the pharmacy/point of sale. Join us in June to proactively prepare.

Celebrating its 15th year since inception, CBI’s Commercial Contract & Chargeback Excellence is a must-attend for pricing and contracting professionals. Join industry peers for incomparable networking opportunities and forward-thinking content from an array of expert stakeholders. This event offers interactive dialogue and best practices in a rapidly changing market to optimize contract decisions and management, improve chargeback adjudication processes, navigate class of trade complexities and streamline membership management.

Interactive Discussions and Benchmarking with Multi-Stakeholder Perspectives:

  • Key trends and drivers of change impacting the commercial contracting landscape and market access
  • New strategies for risk-share agreements and
    value-based contracting
  • Optimize data exchange between trading partners
    from the wholesaler perspective
  • GPO Best practices for streamlined membership management and accountability
  • Valuable strategies for payer cost control approaches in the contracting space
  • Impact of HHS Proposed Rule to eliminate prescription drug rebates on contracting stakeholders

Previous Attendee Acclaim:

This conference gathers industry experts to inform,
spark discussion and provide valuable insight.

Chargeback & Rebate Analyst, Octapharma USA, Inc.

The knowledge and understanding of
the speakers was top-notch.

340B Liaison/Analyst, McKesson

Good mix of speakers, panelists and discussion.

Executive Director, Pricing & Contract Administration, Purdue Pharma

Overall enjoyed the variety of formats of all sessions!

Manager, Sales Processing/Data Governance, Hospira